Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.09 USD | -0.39% |
|
-7.60% | -36.10% |
06-20 | Bayer, Orion's Prostate Cancer Treatment Recommended for EU Approval in Third Indication | MT |
06-20 | Orion Receives $100 Million in New Contracts | MT |
Evolution of the Average Target: Orion S.A.
Evolution of the Target Price: Orion S.A.
Changes in Analyst Recommendations: Orion S.A.
914cb9e.xpnK5JFPJCd0TQmiiF8Q676FDNS2uUxoCrr7p78XHJc.hfuck9InYEkeC0PmsRVaqfLTOOHb9RoqZsyvxexTfa-D66Ld4gVIQx43WA~2e0f06b91330fdef96fe2fcde200c5b0
More recommendations
Consensus (Composite) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+40.73% | ||||||
+4.39% | ||||||
+5.23% | ||||||
+23.63% | ||||||
+27.98% | ||||||
+12.68% | ||||||
+19.72% | ||||||
+13.19% | ||||||
+20.85% | ||||||
+52.3% | ||||||
Average | +22.07% | |||||
Weighted average by Cap. | +14.55% |
Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.09USD
Average target price
14.20USD
Spread / Average Target
+40.73%
High Price Target
19.00USD
Spread / Highest target
+88.31%
Low Price Target
10.00USD
Spread / Lowest Target
-0.89%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
UBS | |
JPMorgan Chase | |
Mizuho Securities | |
Credit Suisse | |
Barclays | |
Jefferies & Co. | |
Loop Capital |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OEC Stock
- Consensus Orion S.A.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition